P03366 (POL_HV1B1) Human immunodeficiency virus type 1 group M subtype B (isolate BH10)(HIV-1)

Gag-Pol polyprotein UniProtKBInterProInteractive Modelling

1447 aa; Sequence (Fasta)

Available Structures

328 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Crystal structure of AZT-resistant HIV-1 Reverse Transcriptase crosslinked to a DSDNA with a bound … Heteromer
MG;ZP4;GOL;600-1159
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with THR-50 Heteromer
T50;600-1157
Assess
HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX Heteromer
600-1157
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R … Heteromer
P03367;
AAA;600-1157
Assess
Crystal structure of HIV-1 reverse transcriptase covalently tethered to DNA template-primer solved … Heteromer
P01868;
GOL;MG;GLC;600-1157
Assess
Crystal structure of AZT-Resistant HIV-1 Reverse Transcriptase crosslinked to post-translocation AZ… Heteromer
MG;600-1157
Assess
HIV-1 Reverse Transcriptase Crosslinked to pre-translocation AZTMP-terminated DNA (complex N) Heteromer
I6L991; P01868;
MG;600-1157
Assess
STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNU… Heteromer
TBO;600-1157
Assess
Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcriptase (RT) in Complex with Nonnucleos… Heteromer
MN;HBY;600-1157
Assess
HIV-1 reverse transcriptase crosslinked to tenofovir terminated template-primer (complex P) Heteromer
MG;600-1157
Assess
HIV-1 Reverse Transcriptase Crosslinked to Post-Translocation AZTMP-Terminated DNA (Complex P) Heteromer
P01837; P01868;
MG;600-1157
Assess
CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDE… Heteromer
600-1157
Assess
Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhib… Heteromer
NNC;600-1156
Assess
Crystal structure of HIV-1 RT bound to A 6-vinylpyrimidine inhibitor Heteromer
EDM;600-1155
Assess
Crystal structure of the HIV-1 reverse transcriptase bound to a 6-vinylpyrimidine inhibitor Heteromer
EDM;600-1155
Assess
CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE Heteromer
600-1155
Assess
Structure of HIV-1 reverse transcriptase initiation complex core with nevirapine Heteromer
MG;NVP;601-1156
Assess
+1 extended HIV-1 reverse transcriptase initiation complex core (pre-translocation state) Heteromer
P04585;
602-1157
Assess
Crystal Structure of an N-Hydroxythienopyrimidine-2,4-dione RNase H Active Site Inhibitor with Mult… Heteromer
MN;ZW2;PGE; 33×EDO;600-1154
Assess
Structure of HIV-1 Reverse Transcriptase (RT) in complex with dsDNA and (-)3TC-TP Heteromer
MG;SO4;1RZ;600-1154
Assess
STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETE… Heteromer
NVP;601-1155
Assess
+3 extended HIV-1 reverse transcriptase initiation complex core (intermediate state) Heteromer
P04585;
603-1157
Assess
Structure of HIV-1 reverse transcriptase initiation complex core with efavirenz Heteromer
MG;EFZ;603-1157
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with Rilpivirine (TMC278, Edurant)… Heteromer
T27;SO4;EDO;MG;600-1153
Assess
HIV-1 reverse transcriptase with bound fragment at the incoming dNTP binding site Heteromer
T27;MG; 11×DMS;14N;600-1153
Assess
HIV-1 reverse transcriptase with bound fragment at NNRTI adjacent site Heteromer
1QP; 10×DMS;T27;600-1153
Assess
Crystal structure of HIV-1 K103N mutant reverse transcriptase in complex with non-nucleoside inhibi… Heteromer
K5C;MG; 10×SO4; 14×EDO;DMS;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase in complex with non-nucleoside inhibitor K-5a2 Heteromer
K5A;MG;SO4; 23×EDO;600-1153
Assess
Crystal structure of HIV-1 Y188L mutant reverse transcriptase in complex with non-nucleoside inhibi… Heteromer
K5A;MG;NA;SO4; 23×EDO;600-1153
Assess
HIV-1 reverse transcriptase with bound fragment at the RNase H primer grip site Heteromer
T27; 17×DMS;1FF;MG;600-1153
Assess
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH an anilinylpyrimidine derivat… Heteromer
JLJ;SO4;EDO;600-1153
Assess
HIV-1 reverse transcriptase with bound fragment near Knuckles site Heteromer
T27; 15×DMS;J94;600-1153
Assess
Crystal structure of HIV-1 E138K mutant reverse transcriptase in complex with non-nucleoside inhibi… Heteromer
K5A;MG;NA;SO4; 26×EDO;600-1153
Assess
Crystal structure of HIV-1 K103N mutant reverse transcriptase in complex with non-nucleoside inhibi… Heteromer
K5A;MG;DMS; 10×SO4; 30×EDO;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase V106A/F227L mutant in complex with non-nucleoside … Heteromer
K5C;MG;SO4; 18×EDO;DMS;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase in complex with non-nucleoside inhibitor 25a Heteromer
K5C;MG;SO4; 22×EDO;DMS;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase Y181I mutant in complex with non-nucleoside inhibi… Heteromer
K5C;MG;SO4; 28×EDO;DMS;600-1153
Assess
Crystal Structure of HIV-1 RT in Complex with 16c (K07-15) Heteromer
SO4;EDO;MG;K7F;600-1153
Assess
Crystal structure of HIV-1 K103N/Y181C mutant reverse transcriptase in complex with non-nucleoside … Heteromer
K5C;MG;SO4; 31×EDO;DMS;600-1153
Assess
Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-Ray Crystallographic Fragment Screen… Heteromer
T27;FMQ; 11×DMS;MG;600-1153
Assess
Crystal structure of HIV-1 E138K mutant reverse transcriptase in complex with non-nucleoside inhibi… Heteromer
K5C;MG;SO4; 27×EDO;DMS;600-1153
Assess
HIV-1 reverse transcriptase with bound fragment at the 428 site Heteromer
T27;1FE;MG; 16×DMS;600-1153
Assess
HIV-1 reverse transcriptase with bound fragment at the Knuckles site Heteromer
T27;MG; 16×DMS;1FD;600-1153
Assess
HIV-1 reverse transcriptase complexed with 4-iodopyrazole Heteromer
T27;SO4;EDO; 14×IOD;PYZ;DMS;600-1153
Assess
Structure of HIV-1 reverse transcriptase (RT) in complex with rilpivirine and an RNase H inhibitor … Heteromer
T27;BA5;MG;SO4;EDO;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase K101P mutant in complex with non-nucleoside inhibi… Heteromer
K5C;MG;SO4; 24×EDO;DMS;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with 4-[(4-{4-[(E)-2-cyanoethenyl]… Heteromer
QAG;SO4;EDO;MG;600-1153
Assess
HIV-1 reverse transcriptase with bound fragment at the 507 site Heteromer
1FG;DMS;600-1153
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyri… Heteromer
UMY;SO4;MG;601-1154
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
GLC;MG;DTP;SO4;EDO;600-1153
Assess
STRUCTURE OF Q151M complex (A62V, V75I, F77L, F116Y, Q151M) mutant HIV-1 REVERSE TRANSCRIPTASE (RT)… Heteromer
GLC;MG;DTP;EDO;SO4;600-1153
Assess
Crystal structure of the HIV-1 reverse transcriptase (RT) in complex with the alkenyldiarylmethane … Heteromer
AC7;600-1153
Assess
STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED D… Heteromer
GLC;MG;DTP;EDO;600-1153
Assess
STRUCTURE OF Q151M complex (A62V, V75I, F77L, F116Y, Q151M) mutant HIV-1 REVERSE TRANSCRIPTASE (RT)… Heteromer
GLC;MG;DDS;SO4;EDO;600-1153
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
GLC;MG;DDS;EDO;SO4;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) cross-linked with AZT-terminated DNA Heteromer
600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) with DNA and AZTTP Heteromer
MG;AZT;600-1153
Assess
Crystal Structure of HIV-1 reverse transcriptase (RT) in complex with the Non-nucleoside RT Inhibit… Heteromer
UDR;600-1153
Assess
Structure of HIV-1 Reverse Transcriptase Bound to a 38-mer Hairpin Template-Primer RNA-DNA Aptamer Heteromer
GLC;MG;GOL;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) with DNA and the nonnucleoside inhibitor nevi… Heteromer
NVP;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) with DNA and a nucleoside triphosphate mimic … Heteromer
GLC;MG;3JY;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase in complex with RNA/DNA and Nevirapine Heteromer
NVP;600-1153
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE In COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAM… Heteromer
GLC;MG;64A;SO4;GOL;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase in complex with bulge-RNA/DNA and Nevirapine Heteromer
NVP;CA;SO4;600-1153
Assess
HIV-1 reverse transcriptase crosslinked to template-primer with tenofovir-diphosphate bound as the … Heteromer
P04585;
MG;TNV;GOL;600-1153
Assess
K65R mutant HIV-1 reverse transcriptase cross-linked to DS-DNA and complexed with tenofovir-diphosp… Heteromer
TNV;MG;SO4;600-1153
Assess
Crystal Structure of a Dihydroxycoumarin RNase H Active-Site Inhibitor in Complex with HIV-1 Revers… Heteromer
NVP;F95;MN;600-1153
Assess
Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcriptase (RT) in Complex with IDX899 Heteromer
5DV;600-1153
Assess
STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG… Heteromer
P04585;
MG;TTP;600-1153
Assess
THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 Heteromer
MG;600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase in complex with gap-RNA/DNA and Nevirapine Heteromer
NVP;MN;600-1153
Assess
K65R mutant HIV-1 reverse transcriptase cross-linked to DS-DNA and complexed with DATP as the incom… Heteromer
DTP;SO4;MG;DDG;600-1153
Assess
Structure of HIV-1 Reverse Transcriptase in complex with a DNA aptamer, AZTTP, and CA(2+) ion Heteromer
CA;AZT;600-1153
Assess
Crystal structure of AZT-resistant HIV-1 Reverse Transcriptase crosslinked to pre-translocation AZT… Heteromer
600-1153
Assess
Structure of HIV-1 reverse transcriptase initiation complex core Heteromer
MG;BOG;603-1156
Assess
Structure of HIV-1 Reverse Transcriptase Bound to a Novel 38-mer Hairpin Template-Primer DNA Aptamer Heteromer
GLC;SO4;GOL;600-1152
Assess
Structure of HIV-1 Reverse Transcriptase in complex with DNA and INDOPY-1 Heteromer
GLC;SO4;NH4;GOL;PEG;PG4;IY1;600-1152
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
MG;D4T;GOL;600-1152
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
MG;D4T;GOL;600-1152
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-… Heteromer
9KD;SO4;601-1153
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
MG;D4T;GOL;600-1152
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
MG;D4T;GOL;600-1152
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
MG;D4T;GOL;600-1152
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
MG;D4T;GOL;600-1152
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… Heteromer
MG;D4T;GOL;600-1152
Assess
Crystal Structure of a Hydroxypyridone Carboxylic Acid Active-Site RNase H Inhibitor in Complex wit… Heteromer
MG;600-1152
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE In COMPLEX WITH A DNA aptamer and FOSCARNET, a Pyrophospha… Heteromer
GLC;MG;PPF;SO4;GOL;ATM;600-1152
Assess
Crystal Structure of a 2-Hydroxyisoquinoline-1,3-dione RNase H Active Site Inhibitor with Multiple … Heteromer
MN;Y55;600-1152
Assess
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA Heteromer
600-1152
Assess
Crystal structure of wild-type HIV-1 Reverse Transcriptase crosslinked to a DSDNA with a bound exci… Heteromer
MG;ZP4;GOL;601-1153
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (RT) in Complex with TMC278 (Rilpivirine), A Non-n… Heteromer
SO4;T27;EDO;600-1151
Assess
Crystal Structure of an engineered form of the HIV-1 Reverse Transcriptase, RT69A Heteromer
SO4;602-1153
Assess
Crystal structure of K103N/Y181C mutant HIV-1 reverse transcriptase (RT) in complex with TMC278 (Ri… Heteromer
T27;EDO;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (K103N, Y181C) Variant in Complex with 2-chloro-N-… Heteromer
9HY;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (K103N, Y181C) Variant in Complex with N-(6-cyano-… Heteromer
9J1;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with 2-chloro-N-(6-cyan… Heteromer
9HY;SO4;600-1151
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with R221239 Heteromer
GLC;GOL;MN;R22;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with N-(6-cyano-3-(2-(2… Heteromer
9KD;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with 5-chloro-7-(2-(2-(… Heteromer
7AY;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-… Heteromer
9KG;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-… Heteromer
9JP;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 2-chloro-N-(6-cyano-3-(2-(2-(2,4-d… Heteromer
9K7;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with N-(6-cyano-3-(2-(2… Heteromer
9J1;SO4;600-1151
Assess
Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with TSAO-T, a non-nucleoside RT i… Heteromer
QO9;600-1151
Assess
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385 Heteromer
ADB;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with N-(6-cyano-3-(2-(2… Heteromer
9JP;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with methyl 2-(6-cyano-3-(2-(2-(2,4-dio… Heteromer
UMV;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) variant in complex with (E)-3-(3-chloro-5-… Heteromer
494;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(cyclopropylmethyl)-7-(2-(2-(2,4… Heteromer
UO4;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (K103N,Y181C) variant in complex with (E)-3-(3-chl… Heteromer
494;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-chloro-7-(2-(2-(2,4-dioxo-3,4-di… Heteromer
7AY;SO4;MG;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in complex with 4-((4-(mesitylamino)-1,3,5-triazin… Heteromer
2RT;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with methyl 2-(6-cyano-… Heteromer
UMV;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with 7-(2-(2-(2,4-dioxo… Heteromer
7AX;SO4;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyri… Heteromer
7AX;600-1151
Assess
HIV-1 Reverse Transcriptase with the Inhibitor beta-Thujaplicinol Bound at the RNase H Active Site Heteromer
JTH;MN;602-1153
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 6-((4-((4-cyanophenyl)amino)-1,3,5… Heteromer
639;SO4;MG;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyri… Heteromer
UNS;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in complex with 4-((4-(mesitylamino)-6-(3-morpholi… Heteromer
2RS;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 4-((4-methoxy-6-(2-morpholinoethox… Heteromer
1RE;600-1151
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with JANSSEN-R165481 Heteromer
MN;3AC;600-1151
Assess
Crystal structure of L100I/K103N mutant HIV-1 reverse transcriptase (RT) in complex with TMC278 (ri… Heteromer
T27;600-1151
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with JANSSEN-R157208 Heteromer
MN;357;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) variant in complex with (E)-3-(3-chloro-5-… Heteromer
3X6;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (K103N, Y181C) variant in complex with (E)-3-(3-ch… Heteromer
3X6;600-1151
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with DHBNH, an RNASE H inhibitor Heteromer
Q8UM83;
GLC;GLC;K05;MG;600-1151
Assess
Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcriptase (RT) in Complex with ATP Heteromer
MN;NA;ATP;GOL;600-1150
Assess
Crystal structure of unliganded AZT-resistant HIV-1 Reverse Transcriptase Heteromer
600-1150
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE In COMPLEX WITH A DNA aptamer and an Alpha-carboxy nucleos… Heteromer
GLC;MG;3JY;SO4;603-1153
Assess
Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhib… Heteromer
NNI;600-1150
Assess
Diabody bound to a Reverse Transcriptase Aptamer Complex Heteromer
11×SO4;GOL;601-1151
Assess
Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhib… Heteromer
NNB;600-1150
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-4-(3-(2-cyanovinyl)-5-fluoroph… Heteromer
X2G;602-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-4-(3-chloro-5-(2-cyanovinyl)ph… Heteromer
X2J;602-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 4-(3-chloro-5-cyanophenoxy)-3-(2-(… Heteromer
X2S;601-1150
Assess
HIV-1 Reverse Transcriptase Y181C Mutant in complex with JLJ 578 Heteromer
H9Y;MG;SO4;600-1149
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyri… Heteromer
7N1;MG;602-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyri… Heteromer
M9A;MG;SO4;602-1151
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP to A DNA … Heteromer
GLC;MG;GOL;603-1152
Assess
Architecture of HIV-1 reverse transcriptase initiation complex core Heteromer
604-1153
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) with polymorphism mutation K172A and K173A Heteromer
MG; 14×EDO;GOL;600-1148
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-(4-chloro-2-(2-(2,4-dioxo… Heteromer
1YQ;600-1147
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-chloro-5-(4-chloro-2-(2-(… Heteromer
494;EDO;600-1147
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (RT) in Complex with (E)-3-(3-(2-(2-(2,4-dioxo-3,4… Heteromer
506;600-1147
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-bromo-5-(4-chloro-2-(2-(2… Heteromer
1YR;600-1147
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in complex with (E)-3-(3-chloro-5-(2-(2-(2,4-dioxo… Heteromer
3X6;600-1146
Assess
Crystal Structure of HIV-1 Reverse Transcriptase (K101P) Variant in Complex with 8-(2-(2-(2,4-dioxo… Heteromer
29T;600-1146
Assess
HIV-1 reverse transcriptase complexed with 4-bromopyrazole Heteromer
T27; 15×BYZ; 10×DMS;BR;600-1145
Assess
Wildtype HIV-1 Reverse Transcriptase in complex with JLJ 578 Heteromer
H9Y;GOL;602-1147
Assess
Crystal structure of HIV-1 Reverse Transcriptase in complex with RNA/DNA and dATP Heteromer
DTP;MG;EDO;SO4;GOL;600-1144
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-((4-((4-cyanophenyl)amino)-1,3,5… Heteromer
4XO;MG;SO4;600-1144
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 8-(2-(2-(2,4-dioxo-3,4-dihydropyri… Heteromer
29T;603-1146
Assess
HIV-1 Reverse Transcriptase Complexed with CP-94,707 Heteromer
CP9;600-1138
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 4-((6-cyanonaphthalen-1-yl)oxy)-3-… Heteromer
X2V;602-1137
Assess
Crystal Structure of HLA B2705-KK10 Heteromer
P01889; P61769;
GOL;263-272
Assess
Crystal Structure of HLA B2705-KK10-L6M Heteromer
P01889; P61769;
TRS;263-272
Assess
Crystal Structure of C12C TCR-HLAB2705-KK10-L6M Heteromer
P01889; P61769;
SO4;263-272
Assess
KIR3DL1 in complex with HLA-B*57:01-TW10 Heteromer
P01889; P43629; P61769;
NAG;240-249
Assess
SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF C… Heteromer
P03369;
ACT;1155-1164
Assess
Crystal structure of HLA-B*5801 complex with HIV-1 gag derived peptide TW10 Heteromer
P01889; P61769;
240-249
Assess
KIR3DL1 in complex with HLA-B*57:01 presenting TSNLQEQIGW Heteromer
P01889; P43629; P61769;
NAG;240-249
Assess
Crystal Structure of C12C TCR-HA B2705-KK10 Heteromer
P01889; P61769;
263-272
Assess
Crystal structure of HLA-B*5701 complex with HIV-1 gag derived peptide TW10 Heteromer
P01889; P61769;
240-249
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 Peptide RT468-476 Heteromer
P04439; P61769;
MES;GOL;908-916
Assess
HIV-1 RT/9-CL TIBOhomo-2-merTB9;600-1157
Assess
TYR 181 CYS HIV-1 RT/8-CL TIBOhomo-2-merTBO;600-1157
Assess
TYR 188 LEU HIV-1 RT/HBY 097homo-2-merHBY;600-1157
Assess
Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (…homo-2-merYKN;CA;600-1156
Assess
HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204homo-2-merBFU;600-1156
Assess
K103N Mutant HIV-1 Reverse Transcriptase in Complex with the Inhibitor PNU142721homo-2-merPNU;600-1156
Assess
Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (…homo-2-merYKN;CA;600-1156
Assess
K103N Mutant HIV-1 Reverse Transcriptase in Complex with Efivarenzhomo-2-merEFZ;600-1156
Assess
Wild Type HIV-1 Reverse Transcriptase in Complex with Efavirenzhomo-2-merEFZ;600-1156
Assess
HIV-1 Reverse Transcriptase in Complex with the Inhibitor MSC194homo-2-merMSD;600-1156
Assess
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1homo-2-mer600-1155
Assess
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1homo-2-merHBY;600-1155
Assess
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1homo-2-merAAP;600-1155
Assess
HIV-1 RT/HBY 097homo-2-merHBY;600-1155
Assess
Crystal Structure of a 1,2,4-Triazole Allosteric RNase H Inhibitor in Complex with HIV Reverse Tran…homo-2-merMN;T90;600-1153
Assess
HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-METHIONINE TENOFOVIR WITH BOUND MANGANESEhomo-2-merMN;RFE;600-1153
Assess
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1homo-2-mer600-1153
Assess
HIV-1 Reverse Transcriptase in Complex with Manicol at the RNase H Active Site and TMC278 (Rilpivir…homo-2-merMNK;T27;MN;DMS;EDO;600-1153
Assess
Crystal structure of K103N/Y181C mutant of HIV-1 reverse transcriptase in complex with rilpivirine …homo-2-mer1BT;EDO;600-1153
Assess
Crystal Structure of a 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione Inhibitor in Complex with H…homo-2-merJ63;MG;600-1153
Assess
HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND D-ASPARTATE TENOFOVIR WITH BOUND MANGANESEhomo-2-merMN;REK;600-1153
Assess
HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-GLUTAMATE TENOFOVIR WITH BOUND MANGANESEhomo-2-merMN;RE5;600-1153
Assess
HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-METHIONINE TENOFOVIRhomo-2-mer600-1153
Assess
HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-GLUTAMATE TENOFOVIRhomo-2-mer600-1153
Assess
HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND D-ASPARTATE TENOFOVIRhomo-2-mer600-1153
Assess
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA P…homo-2-mer600-1153
Assess
Crystal structure of HIV-1 reverse transcriptase (RT) in complex with a double stranded RNA represe…homo-2-merGLC;MG;600-1152
Assess
Crystal structure of HIV-1 reverse transcriptase in complex with rilpivirine (TMC278) based analoguehomo-2-merG73;600-1151
Assess
CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335homo-2-mer65B;600-1151
Assess
CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH…homo-2-merMG;IET;600-1151
Assess
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681homo-2-merTPB;600-1151
Assess
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545homo-2-merMG;185;600-1151
Assess
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyri…homo-2-mer3LQ;MG;SO4;601-1147
Assess
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.homo-2-merABZ;600-1142
Assess
Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding sitehomo-2-merSO4;CL;ACY;1216-1368
Assess
Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors …homo-2-merMG;9VN;SO4;1216-1367
Assess
Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors …homo-2-merMG;9VK;SO4;1216-1367
Assess
Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors …homo-2-merMG;1216-1367
Assess
Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors …homo-2-merMG;9VN;SO4;1216-1367
Assess
Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors …homo-2-mer9VK;MG;1216-1367
Assess
Crystal Structure of the HIV-1 Integrase catalytic domain with GSK1264homo-2-mer2SQ;CAC;SO4;1217-1366
Assess
CRYSTAL STRUCTURE OF THE RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASEhomo-2-mer1026-1155
Assess
crystal structure of HIV protease model precursor/Saquinavir complexhomo-2-merROC;CL;NA;GOL;497-599
Assess
crystal structure of HIV model protease precursor/saquinavir complexhomo-2-merCL;GOL;ROC;497-599
Assess
Crystal structure of HIV protease model precursor/Darunavir complexhomo-2-merCL;NA;017;GOL;497-599
Assess
Wild Type HIV-1 Protease with Antiviral Drug Amprenavirhomo-2-merNA;CL;478;GOL;501-599
Assess
HIV-1 wild Type protease with GRL-0648A (a isophthalamide-derived P2-Ligand)homo-2-merNA;CL;GOL;G64;501-599
Assess
Crystal Structure of HIV-1 Protease Mutant I54M with Antiviral Drug Amprenavirhomo-2-merCL;NA;ACT;478;501-599
Assess
HIV-1 wild Type protease with GRL-031-14A (a Adamantane P1-Ligand with tetrahydropyrano-tetrahydrof…homo-2-merNA;CL;GOL;6KR;501-599
Assess
Crystal Structure of HIV-1 Protease Mutant V32I with Antiviral Drug Amprenavirhomo-2-merNA;CL;478;501-599
Assess
Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II)homo-2-merCL;QHA;501-599
Assess
Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II)homo-2-merCL;C7W;501-599
Assess
Crystal structure of wild-type HIV-1 protease with new oxatricyclic designed inhibitor GRL-0519Ahomo-2-merG52;NA;CL;GOL;501-599
Assess
HIV-1 wild Type protease with GRL-0518A , an isophthalamide-derived P2-P3 ligand with the para-hydo…homo-2-mer8HD;NA;CL;GOL;501-599
Assess
Crystal Structure of HIV-1 Protease Mutant I50V with Antiviral Drug Amprenavirhomo-2-merNA;CL;ACT;478;501-599
Assess
HIV-1 wild Type protease with GRL-047-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, 4-amino sul…homo-2-mer4UX;NA;CL;ACT;501-599
Assess
HIV-1 wild Type protease with GRL-050-10A (a Gem-difluoro-bis-Tetrahydrofuran as P2-Ligand)homo-2-merG10;NA;CL;ACT;501-599
Assess
Crystal structure of multidrug resistant clinical isolate PR20 with GRL-5010Ahomo-2-merG10;Y1;CL;NA;GOL;501-599
Assess
100K X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate…homo-2-merKVS;501-599
Assess
HIV-1 wild Type protease with GRL-1118A , an isophthalamide-derived P2-P3 ligand with the sulfonami…homo-2-mer8FP;NA;CL;GOL;ACT;501-599
Assess
HIV-1 wild Type protease with GRL-011-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, sulfonamide…homo-2-merNA;CL;4UY;501-599
Assess
Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II)homo-2-merCL;ZLP;501-599
Assess
Crystal Structure of HIV-1 Protease Mutant L90M with Antiviral Drug Amprenavirhomo-2-mer19×IOD;478;501-599
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 with Inhibitor GRL-44…homo-2-merY1;CL;GOL;G04;501-599
Assess
New crystal form of HIV-1 Protease/Saquinavir structure reveals carbamylation of N-terminal prolinehomo-2-merDMS;ROC;CL;501-599
Assess
HIV-1 wild type protease with a substituted bis-Tetrahydrofuran inhibitor, GRL-044-10Ahomo-2-merG04;NA;CL;GOL;501-599
Assess
Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II)homo-2-merCL;C7L;501-599
Assess
Wild-type HIV-1 protease in complex with a substrate analog CA-p2homo-2-merNA;CL;FMT;0Q4;GOL;501-599
Assess
HIV-1 wild Type protease with GRL-097-13A (a Adamantane P1-Ligand with bis-THF in P2 and isobutylam…homo-2-merNA;CL;6KK;501-599
Assess
Crystal Structure of HIV-1 Protease Mutant I54V with Antiviral Drug Amprenavirhomo-2-mer19×IOD;478;501-599
Assess
Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II)homo-2-merCL;J5L;501-599
Assess
Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II)homo-2-merCL;VXL;501-599
Assess
Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II)homo-2-merCL;C7U;501-599
Assess
Structure of A17 HIV-1 Protease in Complex with Inhibitor KNI-1657homo-2-mer8Z0;GOL;501-599
Assess
HIV-1 wild Type protease with GRL-096-13A (a Boc-derivative P2-Ligand, 3,-5-dimethylbiphenyl P1-Lig…homo-2-merNA;CL;G61;ACT;501-599
Assess
HIV-1 wild Type protease with GRL-100-13A (a Crown-like Oxotricyclic Core as the P2-Ligand with the…homo-2-merNA;CL;8FM;501-599
Assess
Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitorshomo-2-merCL;M8Y;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;1T8;501-599
Assess
Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitorshomo-2-merCL;EQM;501-599
Assess
Wild-type HIV-1 protease in complex with a phenylboronic acid (P2') analog of darunavirhomo-2-merBVR;CL;GOL;501-599
Assess
HIV-1 Protease complexed with Inhibitor: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2S)-1-(1-…homo-2-mer8BG;501-599
Assess
Crystal structure of wild-type HIV-1 protease with a novel HIV-1 inhibitor GRL-14213A of 6-5-5-ring…homo-2-merNA;CL;7OA;ACT;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;1T8;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;V78;501-599
Assess
HIV-1 wild Type protease with GRL-007-14A (a Adamantane P1-Ligand with bis-THF in P2 and benzylamin…homo-2-merCL;6KQ;501-599
Assess
Structure of HIV1 protease and hh1_173_3a complex.homo-2-merHH1;501-599
Assess
HIV-1 Protease Saquinavir:Ritonavir 1:1 complex structurehomo-2-merROC;CL;DMS;NA;501-599
Assess
Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State…homo-2-merHI1;501-599
Assess
Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State…homo-2-merHV1;501-599
Assess
HIV-1 protease in complex with the inhibitor bea403homo-2-merBED;501-599
Assess
HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitorhomo-2-merBE4;501-599
Assess
HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitorhomo-2-merBE3;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;378;501-599
Assess
CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR, AHA024homo-2-merAHF;501-599
Assess
HIV-1 protease in complex with the inhibitor MSA367homo-2-merMS3;501-599
Assess
Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitorshomo-2-merCL;M8B;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;9MW;501-599
Assess
INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF…homo-2-merA79;501-599
Assess
HIV-1 protease in complex with the inhibitor BEA322homo-2-merBEI;501-599
Assess
HIV-1 Protease in complex with the inhibitor BEA435homo-2-merBEH;501-599
Assess
HIV-1 protease in complex with the inhibitor BEA425homo-2-merBEG;501-599
Assess
HIV-1 protease in complex with the inhibitor MSL370homo-2-merMSC;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;V78;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;J3W;501-599
Assess
Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavirhomo-2-mer478; 30×IOD;501-599
Assess
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-087-13homo-2-merFQ4;501-599
Assess
Structural and kinetic analysis of drug resistant mutants of HIV-1 proteasehomo-2-mer0Q4;501-599
Assess
HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitorhomo-2-merBE6;501-599
Assess
HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450homo-2-merDMQ;501-599
Assess
HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323homo-2-merDMP;501-599
Assess
HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitorhomo-2-merBE5;501-599
Assess
HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323homo-2-merDMP;501-599
Assess
HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323homo-2-merDMP;501-599
Assess
D30N HIV-1 protease in complex with a phenylboronic acid (P2') analog of darunavirhomo-2-merCL;BVR;GOL;501-599
Assess
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-084-13homo-2-merFQ1;501-599
Assess
Crystal Structure of Complex of a Hydroxyethylamine Inhibitor with HIV-1 Protease at 2.0A Resolutionhomo-2-mer0ZS;501-599
Assess
X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PRO…homo-2-merG37;501-599
Assess
HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001homo-2-merAH1;501-599
Assess
Crystal structure of HIV protease complexed with LGZ479homo-2-merLGZ;501-599
Assess
STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PRhomo-2-mer3TL;501-599
Assess
Crystal structure of HIV-1 protease complexed with LDC271homo-2-merL27;501-599
Assess
HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006homo-2-merNMB;501-599
Assess
Structure of HIV-1 protease bound to atazanavirhomo-2-merDR7;501-599
Assess
crystal structure of HIV-1 protease-huphomo-2-mer3NH;501-599
Assess
ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STR…homo-2-merU0E;501-599
Assess
HIV-1 protease in complex with the inhibitor BEA428homo-2-merBEJ;501-599
Assess
HIV-1 protease in complex with the inhibitor BEA388homo-2-merBEC;501-599
Assess
HIV Protease with Scripps AB-3 Inhibitorhomo-2-merA83;501-599
Assess
Crystal structure of wild type HIV-1 protease (BRU isolate) with a hydroxyethylamine peptidomimetic…homo-2-mer0ZT;501-599
Assess
Structural and kinetic analysis of drug resistant mutants of HIV-1 proteasehomo-2-mer0Q4;501-599
Assess
HIV-1 protease in complex with an isobutyl decorated oligoamine (symmetric binding mode)homo-2-merLJG;CL;501-599
Assess
Crystal Structure of HIV Protease complexed with Arylsulfonamide azacyclic ureahomo-2-merBH0;501-599
Assess
HIV-1 protease in complex with the inhibitor BEA409homo-2-merBEE;501-599
Assess
The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to hum…homo-2-merPSI;501-599
Assess
COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820…homo-2-merBME;C20;501-599
Assess
X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PRO…homo-2-merG26;501-599
Assess
The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to hum…homo-2-mer501-599
Assess
HIV-1 protease in complex with the inhibitor BEA369homo-2-merBEB;501-599
Assess
G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360Ehomo-2-merU0E;501-599
Assess
HIV-1 PROTEASE (WILD TYPE) COMPLEXED WITH U89360E (INHIBITOR)homo-2-merU0E;501-599
Assess
AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLAC…homo-2-merIM1;501-599
Assess
INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRIC PHOSPHINATE SYNTHESIS AND C…homo-2-merPHP;501-599
Assess
RATIONAL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF A HYDROXYETHYLENE-BASED HIV-1 PROTEASE …homo-2-merRUN;501-599
Assess
A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMM…homo-2-merGAN;501-599
Assess
HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR)homo-2-merU0E;501-599
Assess
HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR)homo-2-merU0E;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;9MW;501-599
Assess
Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcoholhomo-2-merCL;M17;501-599
Assess
HIV Protease inhibitors with pseudo-symmetric coreshomo-2-merGGW;501-599
Assess
HIV Protease, pseudo-symmetric inhibitorshomo-2-merGGX;501-599
Assess
X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PRO…homo-2-merG23;501-599
Assess
HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye sitehomo-2-mer3TL;HV9;DMS;501-599
Assess
HIV Protease with oximinoarylsulfonamide boundhomo-2-merOIS;501-599
Assess
HIV Protease, pseudo-symmetric inhibitorshomo-2-merGGV;501-599
Assess
C-terminal DNA-binding domain of HIV-1 integrase, NMR, 42 structureshomo-2-mer1379-1429
Assess
2.2 ANGSTROMS RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1 REVERSE TRANSCRIPTASE (FINGE…monomer600-815
Assess
Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNASE H domain of HIV-1 …monomerMN;F95;1024-1156
Assess
HIV-1 Reverse Transcriptase Isolated RnaseH Domain with the Inhibitor beta-thujaplicinol Bound at t…monomerMN;JTH;1026-1156
Assess
CRYSTALLOGRAPHIC ANALYSES OF AN ACTIVE HIV-1 RIBONUCLEASE H DOMAIN SHOW STRUCTURAL FEATURES THAT DI…monomer1026-1155
Assess
Structural insights into the cTAR DNA recognition by the HIV-1 Nucleocapsid protein: role of sugar …monomerZN;388-432
Assess
How the HIV-1 nucleocapsid protein binds and destabilises the (-)primer binding site during reverse…monomerZN;390-432
Assess
Solution structure of the HIV-1 nucleocapsid (NCp7(12-55)) complexed with the DNA (-) Primer Bindin…monomerZN;390-432
Assess
C-terminal zinc knuckle of the HIVNCp7 with DNAmonomerZN;411-429
Assess
C-terminal zinc finger of the HIVNCp7 with platinated DNAmonomerZN;411-429
Assess

8 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
homo-2-merI15;0.772jle.1.A600-1144
98.94
Assess
monomerZN;0.736rwl.1.B1160-1431
75.00
Assess
monomerZN;0.736rwl.1.A1160-1428
75.00
Assess
homo-8-mer0.726put.1.G1176-1433
92.28
Assess
homo-6-mer0.716skk.1.A133-352
100.00
Assess
homo-4-mer0.705u1c.1.A1176-1428
91.91
Assess
monomer0.681l6n.1.A2-283
96.11
Assess
homo-18-mer0.667asl.1.A143-377
99.15
Assess

Alignments